Senate Session
The Senate continued working on fast-track trade authority promotion legislation. Senator Rand Paul (R-KY) spoke for…
| Clip Of Senate Session, Part 1
Report Video IssueSenators Kelly Ayotte and Edward Markey on Prescription Drug Abuse
2016-02-23T11:19:15-05:00https://images.c-span.org/Files/491/1456255952.jpgSenators Kelly Ayotte (R-NH) and Edward Markey (D-MA) criticize the FDA for the agency's response to heroin and prescription drug abuse. They also say they oppose Dr. Robert Califf's nomination to be FDA commissioner because of his record on the topic.
Senators Kelly Ayotte (R-NH) and Edward Markey (D-MA) criticize the FDA for the agency's response to heroin and prescription drug abuse. They also say they oppose Dr. Robert Califf's nomination to be FDA commissioner because of his record on the topic.
People in this video
- Kelly A. Ayotte U.S. Senator (Class 3) [R] New Hampshire
- Dick Durbin U.S. Senator (Class 2) [D] Illinois
- Edward J. Markey U.S. Senator (Class 2) [D] Massachusetts
Hosting Organization
Series
More Videos From
U.S. Senate
- Senator Reid on Supreme Court Justice Nomination
- Senate Session, Part 2
- Senator Leahy on Supreme Court Justice Nomination
- Senator Roberts on Closing Guantanamo
- Senator McConnell on Closing Guantanamo
- Senators on Supreme Court Justice Nomination
Purchase a Download
Senators Kelly Ayotte and Edward Markey on Prescription Drug Abuse
-
MP4 video - Standard
- Price:
- $4.99
-
MP3 audio - Standard
- Price:
- $0.99
Related Video
-
-
Senate Session
Following leader remarks and a period of morning business, senators were to vote on the motion to proceed to H.R. 2578,…
-
Senate Session
The Senate convened for a legislative session. Business was postponed until the next day. Senator Lisa Murkowski (R-AK)…
-
Senate Session, Part 1
The Senate began debate on S. 2280, a bill sponsored by Senators John Hoeven (R-ND) and Mary Landrieu (D-LA) to approve…
User Created Clips from This Video
-
- 28 minutes
- 490 views
-
- 8 minutes
- 489 views
-
- 57 minutes
- 184 views
-
- 2 minutes
- 30 views